← Leaderboards
Evelyn Horn
Columbia University Health Sciences
$901,569
Attributed
$2,033,727
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $548.6K · FY2014–18$1M$750K$500K$250K$0
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$2,033,727 · 2
By mechanism
U01$1,572,547 · 1
R21$461,180 · 1
Top collaborators
- Erika S. Berman-Rosenzweig5 shared
- Mathew S Maurer2 shared
- Sean P Pinney2 shared
- Alex Reyentovich2 shared
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- David Sulzer$25,519,828
- Kristi Reynolds$7,536,209
- Mathew S Maurer$11,052,259
- Thomas L. Nickolas$5,747,594
- Mary Sano$40,764,266
Others in their field
Top investigators on “Hemodynamics”
- Alan Jasanoff · Massachusetts Institute Of Technology$22,516,687
- Jay D Humphrey · Yale University$22,350,674
- Angela L. Jefferson · Vanderbilt University Medical Center$21,651,697
- Robert Freedman · University Of Colorado Denver$20,038,696
- Danny Bluestein · State University New York Stony Brook$18,226,851
- Kent A Kiehl · Hartford Hospital$17,001,778
Research focus
HemodynamicsSiteCohortPhysiologicalFutureCostPhenotypeTherapeutic InterventionClinical PhenotypeCustomBiological MarkersBioinformaticsCrosslinkBloodDeep SequencingClassificationBrain Hypoxia-IschemiaDna ResequencingCav1 GeneBaseCandidate Disease GeneBiochemicalBmpr2 GeneCdna Library
Grant awards (7)
PVDOMICS Defining the Future Fingerprints of Pulmonary Vascular Disease$328,855
U01 · FY2018 · HL
PVDOMICS Defining the Future Fingerprints of Pulmonary Vascular Disease$328,855
U01 · FY2017 · HL
PVDOMICS Defining the Future Fingerprints of Pulmonary Vascular Disease$328,855
U01 · FY2016 · HL
PVDOMICS Defining the Future Fingerprints of Pulmonary Vascular Disease$323,922
U01 · FY2015 · HL
Can Ventricular Assist Devices Reverse the Frailty Phenotype$224,686
R21 · FY2015 · AG
PVDOMICS Defining the Future Fingerprints of Pulmonary Vascular Disease$262,060
U01 · FY2014 · HL
Can Ventricular Assist Devices Reverse the Frailty Phenotype$236,494
R21 · FY2014 · AG